US Health Panel Reviews J&J Vaccine Pause Over Rare Clots
With the U.S. pause of Johnson & Johnsonβs COVID-19 vaccine stretched into a second week, authorities are weighing whether to resume the shots the way European regulators decided to β with warnings of a βvery rareβ risk.
